Crossmark

Novel Antimicrobial Peptide SAAP Mutant as a Better Adjuvant to Sulbactam-Based Treatments Against Clinical Strains of XDR Acinetobacter baumannii

Crossref DOI link: https://doi.org/10.1007/s12602-023-10067-5

Published Online: 2023-03-27

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Naha, Aniket https://orcid.org/0000-0002-6811-9767
Ramaiah, Sudha https://orcid.org/0000-0002-4800-329X
License Information

Text and Data Mining valid from 2023-03-27

Version of Record valid from 2023-03-27
More Information

Article History

Accepted: 20 March 2023

First Online: 27 March 2023

Declarations

:

: The authors declare no competing interests.